ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Lighting a Fire: Gasdermin-Mediated Pyroptosis Remodels the Glioma Microenvironment and Promotes Immune Checkpoint Blockade Response

Cai, Yonghua; Li, Ke; Lin, Jie; Liang, Xianqiu; Xu, Wei; Zhan, Zhengming; Xue, Shuaishuai; Zeng, Yu; Chai, Peng; Mao, Yangqi; Song, Zibin; Han, Lei; Song, Ye*; Zhang, Xian*; Wang, Hai*南方医科大学; y
Frontiers in Immunology2022-6-17DOI: 10.3389/fimmu.2022.910490
2被引7阅读
引用收藏
分享

摘要

Pyroptosis is a proinflammatory programmed cell death pathway mediated by gasdermins. Exploring the role of pyroptosis can provide new insights into tumor malignancy. The most recent studies on pyroptosis have focused on tumor cells. However, the effects of pyroptosis on the tumor microenvironment (TME), immunotherapeutic responses, and efficacy have been neglected, especially in case of glioma. In this study, four independent glioma cohorts comprising 1,339 samples and a pan-cancer cohort comprising 10,535 tumor samples were analyzed. The relationships among pyroptosis status, prognosis, microenvironment cellular components, and clinical and biological phenotypes were investigated through the identification of pyroptosis subtypes, construction of a gasdermin-related prognostic index (GPI), and evaluation of immunological characteristics in glioma. The Genomics of Drug Sensitivity in Cancer database and "pRRophetic" package in R were used to estimate temozolomide (TMZ) sensitivity. The "Submap" package and external immunotherapy cohorts were used to investigate and confirm the role of GPI in response to and efficacy of immunotherapy in glioma. Finally, potential small-molecule compounds related to GPI were identified using the connectivity map database and mode-of-action analysis. We identified three different pyroptosis subtypes: cluster 1 (C1) characterized by a higher GPI, while cluster 2 (C2) and cluster 3 (C3) characterized by a lower GPI. The high GPI of C1 was associated with glioma progression and worse prognoses, whereas the low GPI of subtype C2 and C3 was associated with better prognoses. However, patients with high GPIs were found to be more sensitive to TMZ and immune checkpoint blockade than those with low GPIs. Furthermore, gasdermin D may be a principal potential biomarker and play key roles in pyroptosis-inducible therapy combined with immunotherapy in glioma. This study provides a clinical, biological, and molecular landscape of pyroptosis and suggests that pyroptosis of glioma cells may perform the dual function of promoting both tumorigenesis and antitumor immunity.

学科与关键词

关键词
pyroptosisimmunityimmunotherapygasderminstumor immune microenvironmentglioma
相关
加载中…
  • Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
    Zeng, Yu; Cai, Yonghua; Chai, Peng; Mao, Yangqi; Chen, Yanwen; Wang, Li; Zeng, Kunlin; Zhan, Ziling; Xie, Yuxin; Li, Cuiying; Zhan, Hongchao; Zhao, Liqian; Chen, Xiaoxia; Zhu, Xiaoxia; Liu, Yu; Chen, Ming*; Song, Ye*; Zhou, Aidong*Frontiers in Immunology, 2022, 13: 961933.被引 4
  • Comprehensive analysis of pyroptosis-related gene signatures for glioblastoma immune microenvironment and target therapy
    Wang, Zeyu; Dai, Ziyu; Zhang, Hao; Zhang, Nan; Liang, Xisong; Peng, Luo; Zhang, Jian; Liu, Zaoqu; Peng, Yun; Cheng, Quan*; Liu, Zhixiong*Cell Proliferation, 2023, 56(3).被引 1
  • Integrative analysis to screen novel pyroptosis-related LncRNAs for predicting clinical outcome of glioma and validation in tumor tissue
    Ma, Shuai; Zhao, Hongtao; Wang, Fang; Peng, Lulu; Zhang, Heng; Wang, Zaibin; Jiang, Fan; Zhang, Dongtao; Yin, Menglei; Li, Shupeng; Huang, Jiaming*; Liu, Zhan*; Tao, Shengzhong*Aging-US, 2023, 15(5): 1628-1651.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-06-17
卷期
第 13 卷
页码
910490
DOI
10.3389/fimmu.2022.910490
语言
ENGLISH
期刊等级
2区
成果收录
SCIE

作者

  • C

    Cai, Yonghua (第一作者)

    southern med univ

  • L

    Li, Ke

    southern med univ

查看全部 15 位作者收起作者
  • L

    Lin, Jie

    southern med univ

  • L

    Liang, Xianqiu

    southern med univ

  • X

    Xu, Wei

    southern med univ

  • Z

    Zhan, Zhengming

    southern med univ

  • X

    Xue, Shuaishuai

    southern med univ

  • Z

    Zeng, Yu

    southern med univ

  • C

    Chai, Peng

    southern med univ

  • M

    Mao, Yangqi

    southern med univ

  • S

    Song, Zibin

    southern med univ

  • H

    Han, Lei

    southern med univ

  • S

    Song, Ye (通讯)

    southern med univ

  • Z

    Zhang, Xian (通讯)

    southern med univ

  • W

    Wang, Hai (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417